ANI Pharmaceuticals | ANIP - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
AbbVie USD -3.27B 628M 2025-12
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 567.1M 21.58M 2025-09
Canopy Growth CAD 736.01M 247.04M 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Knight Therapeutics CAD 766.79M 3.74M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Novartis USD 44.33B 2.28B 2025-09
Omeros USD -228.68M 15.13M 2025-06
Perrigo USD 2.94B 1.51B 2025-12
Sun Pharmaceuticals INR 778.2B 56.02B 2025-09
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12